(Q26753038)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27041288%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

review article

0 references

title

Nail Psoriasis: A Review of Treatment Options (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27041288%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

2 references

12 March 2019

17 June 2019

2 references

12 March 2019

17 June 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27041288%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

Marcel C Pasch

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 April 2016

3 references

12 March 2019

17 June 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27041288%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

3 references

12 March 2019

17 June 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27041288%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

volume

76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27041288%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

page(s)

675-705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27041288%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27041288%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial

31 March 2020

copyright license

2 references

12 March 2019

17 June 2019

on focus list of Wikimedia project

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s40265-016-0564-5

0 references

cites work

Interventions for nail psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Autoimmunogenicity during anti-TNF therapy in patients with psoriasis and psoriatic arthritis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Apremilast: A Review in Psoriasis and Psoriatic Arthritis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Genetic Epidemiology of Psoriasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Anthralin/dithranol in dermatology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Acitretin in psoriasis: an evolving scenario

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Clinical Trial Study in the Treatment of Nail Psoriasis with Pulsed Dye Laser

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

The prevalence of onychomycosis in psoriatic patients: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Infliximab in psoriasis and psoriatic arthritis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

IL-17 targeted therapies for psoriasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Nail psoriasis treated with pulse dye laser

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

The effect of different pulse durations in the treatment of nail psoriasis with 595-nm pulsed dye laser: a randomized, double-blind, intrapatient left-to-right study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Pulsed dye laser in the treatment of nail psoriasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Progress in understanding the immunopathogenesis of psoriasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Pulsed dye laser vs. photodynamic therapy in the treatment of refractory nail psoriasis: a comparative pilot study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Tacalcitol ointment for the treatment of nail psoriasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Management of psoriatic nail disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Treatment of nail psoriasis with a modified regimen of steroid injections

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Psoriasis is associated with increased beta-defensin genomic copy number

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Complications and adverse reactions in the use of newer biologic agents

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Serum sickness due to infliximab in a patient with psoriasis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Topically applied fluorouracil in the treatment of psoriatic nails

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

A 36-week retrospective open trial comparing the efficacy of biological therapies in nail psoriasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Dramatic response of nail psoriasis to infliximab

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Infliximab efficacy in nail psoriasis. A retrospective study in 48 patients.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Psoriasis causes as much disability as other major medical diseases

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

A simplified protocol of steroid injection for psoriatic nail dystrophy

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Intralesional triamcinolone acetonide using the Port-O-Jet and needle injections in localized dermatoses.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Allopurinol in psoriasis--a double-blind study.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

The treatment of psoriatic nail dystrophy with intradermal steroid injections

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Nail psoriasis: a questionnaire-based survey

31 May 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

The burden of psoriasis is not determined by disease severity only.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

The impact of fingernail psoriasis on patients' health-related and disease-specific quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Nail Psoriasis, the unknown burden of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

21 January 2018

Scoring nail psoriasis.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Comparison of nail lacquer clobetasol efficacy at 0.05%, 1% and 8% in nail psoriasis treatment: prospective, controlled and randomized pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Instability of topical ciclosporin emulsion for nail psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Nail psoriasis successfully treated with intralesional methotrexate: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Treatment of psoriatic nails with indigo naturalis oil extract: a non-controlled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

A Chinese Herb, Indigo Naturalis, Extracted in Oil (Lindioil) Used Topically to Treat Psoriatic Nails: A Randomized Clinical Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Efficacy and safety of Indigo naturalis extract in oil (Lindioil) in treating nail psoriasis: a randomized, observer-blind, vehicle-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Evaluation of the efficacy of acitretin therapy for nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Nail lesions in psoriatic arthritis: recovery with sulfasalazine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Leflunomide in psoriatic arthritis: results from a large European prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Treatment of nail psoriasis with adalimumab: an open label unblinded study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Onychomycosis in patients of nail psoriasis on biologic therapy: a randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: an analysis of Japanese clinical trials of infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Marked improvement in nail psoriasis during treatment with adalimumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Efficacy of adalimumab in the treatment of psoriasis: a retrospective study of 15 patients in daily practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Anti-TNF agents and nail psoriasis: a single-center, retrospective, comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Treatment of nail psoriasis with tumor necrosis factor-alpha blocker agents: an open-label, unblinded, comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Ustekinumab for the treatment of nail psoriasis in heavily treated psoriatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Evaluation of a novel 308-nm monochromatic excimer light delivery system in dermatology: a pilot study in different chronic localized dermatoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

A randomized, double-blinded trial evaluating the efficacy and tolerability of vectical ointment (calcitriol 3 mcg/g ointment) when compared to betamethasone diproprionate ointment (64 mg/g) in patients with nail psoriasis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Influence of psoriatic arthritis on the efficacy of adalimumab and on the treatment response of other markers of psoriasis burden: subanalysis of the BELIEVE study.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Etanercept in the treatment and retreatment of psoriasis in daily clinical practice

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Topical calcipotriol therapy in nail psoriasis: a study of 24 cases.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Psoriasis of the nails treated with grenz rays: a double-blind bilateral trial.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4833799

Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study

28 November 2018

1 reference

12 December 2020

Psoriatic nails: a prospective clinical study

1 reference

12 December 2020

Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis

1 reference

12 December 2020

A double-blind study of superficial radiotherapy in psoriatic nail dystrophy

1 reference

12 December 2020

Psoriasis and lichen planus of nalis. Treatment with triamcinolone

1 reference

12 December 2020

Etanercept as monotherapy in patients with psoriasis

1 reference

12 December 2020

Rupture of the extensor pollicis longus tendon: a study of aetiological factors

1 reference

12 December 2020

Remission and time of resolution of nail psoriasis during infliximab therapy

1 reference

12 December 2020

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

1 reference

12 December 2020

Alefacept treatment of psoriatic nail disease: how severe should nail psoriasis be?

1 reference

12 December 2020

A case of nail psoriasis treated with topical calcitriol

1 reference

12 December 2020

Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study

1 reference

12 December 2020

Normalization in the appearance of severly damaged psoriatic nails using soft x-rays. A case report

1 reference

12 December 2020

Successful treatment of psoriatic nails with low-dose cyclosporine administration

1 reference

12 December 2020

Nail psoriasis improvement in a patient treated with fumaric acid esters

1 reference

12 December 2020

Childhood Nail Psoriasis: A Useful Treatment with Tazarotene 0.05%

1 reference

12 December 2020

Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year

1 reference

12 December 2020

Rapid response of nail psoriasis to etanercept

1 reference

12 December 2020

Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis

1 reference

12 December 2020

Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial

1 reference

12 December 2020

Ustekinumab for rapid treatment of nail psoriasis

1 reference

12 December 2020

Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study

1 reference

12 December 2020

UV-A and UV-B penetration of normal human cadaveric fingernail plate

1 reference

12 December 2020

Evaluation of nail disease in psoriatic arthritis by using a modified nail psoriasis severity score index

1 reference

12 December 2020

Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy)

1 reference

12 December 2020

Treatment of severe nail psoriasis with etanercept

1 reference

12 December 2020

Long-term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma

1 reference

12 December 2020

Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial

1 reference

12 December 2020

Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: long-term results from a phase 2/3 clinical trial

1 reference

12 December 2020

Corticosteroid-induced 'disappearing digit'

1 reference

12 December 2020

Marked improvement in nail psoriasis during treatment with etanercept

1 reference

12 December 2020

Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment

1 reference

12 December 2020

Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal

1 reference

12 December 2020

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study

1 reference

12 December 2020

Topical ciclosporin in nail psoriasis

1 reference

12 December 2020

Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study

1 reference

12 December 2020

Effectiveness of systemic treatment agents on psoriatic nails: a comparative study

1 reference

12 December 2020

Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1

1 reference

12 December 2020

Treatment of nail psoriasis with intralesional triamcinolone acetonide using a needle-free jet injector: a prospective trial

1 reference

12 December 2020

Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study

1 reference

12 December 2020

Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis

1 reference

12 December 2020

[Successful local treatment of nail psoriasis with 5-fluorouracil]

1 reference

12 December 2020

1 reference

12 December 2020

Topical ciclosporin for psoriasis: in vitro skin penetration and clinical study

1 reference

12 December 2020

Distal phalangeal atrophy secondary to topical steroid therapy

1 reference

12 December 2020

Local PUVA treatment for nail psoriasis.

1 reference

12 December 2020

Intradermal triamcinolone treatment of nail dystrophies

1 reference

12 December 2020

Finger tendon rupture following local application of triamcinolone-acetonide (Kenalog A-40)

1 reference

12 December 2020

Response of psoriatic nails to oral photochemotherapy

1 reference

12 December 2020

Successful treatment of psoriasis of the nails

1 reference

12 December 2020

A therapeutic study of nail psoriasis using electron beams

1 reference

12 December 2020

Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement

1 reference

12 December 2020

Response of nail psoriasis to cyclosporin

1 reference

12 December 2020

Colloidal silicic acid for the treatment of psoriatic skin lesions, arthropathy and onychopathy. A pilot study

1 reference

12 December 2020

Topical anthralin therapy for refractory nail psoriasis

1 reference

12 December 2020

Anti-interleukin-17 monoclonal antibody ixekizumab in psoriasis

1 reference

https://api.crossref.org/works/10.1007%2FS40265-016-0564-5

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1007/S40265-016-0564-5

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27041288%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

31 March 2020

1037292984

0 references

Fatcat ID

release_wamv7kswofadjmue53apsyalse

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wamv7kswofadjmue53apsyalse

24 November 2022

mapped directly with Wikidata item

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27041288%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27041288%20AND%20SRC:MED&resulttype=core&format=json